10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☑ QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2020

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number:   000-54918

MCORPCX, INC.

(Exact name of registrant as specified in its charter)

California

(State or other jurisdiction of incorporation or organization)

26-0030631

(I.R.S. Employer Identification No.)

201 Spear Street, Suite 1100

San Francisco, CA   94105

(Address of principal executive offices, including zip code)

(415) 526-2655

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days.   YES ☑     NO ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   YES ☑     NO ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer	☐	Accelerated Filer	☐
Non-accelerated Filer	☑	Smaller Reporting Company	☑
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  YES ☐     NO ☑

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
None	N/A	N/A

Indicated the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date: 20,426,158 as of May 13, 2020.   

MCORPCX, Inc.

Form 10-Q Quarterly Report

TABLE OF CONTENTS

		Page No.
	Part I. - Financial Information	3
Item 1.	Financial Statements.	3
	Consolidated Balance Sheets as of March 31, 2020 (unaudited) and December 31, 2019.	3
	Consolidated Statements of Operations for the Three Months ended March 31, 2020 and 2019 (unaudited).	4
	Consolidated Statements of Changes in Shareholders’ Equity for the Three Months ended March 31, 2020 and 2019 (unaudited).	5
	Consolidated Statements of Cash Flows for the Three Months ended March 31, 2020 and 2019 (unaudited).	6
	Notes to Consolidated Financial Statements (unaudited).	7
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations.	12
Item 3.	Quantitative and Qualitative Disclosure about Market Risk.	18
Item 4.	Controls and Procedures.	18
	Part II. - Other Information	18
Item 1.	Legal Proceedings.	18
Item 1A.	Risk Factors.	18
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	20
Item 3.	Defaults Upon Senior Securities.	21
Item 4.	Mine Safety Disclosures.	21
Item 5.	Other Information.	21
Item 6.	Exhibits.	22
Signatures		23

PART I. FINANCIAL INFORMATION

ITEM 1.     FINANCIAL STATEMENTS.

McorpCX, Inc.

Consolidated Balance Sheets

	March 31,			December 31,
	2020			2019
	(unaudited)
Assets
Current assets:
Cash and cash equivalents	$	438,461		$	588,848
Accounts receivable		399,338			486,317
Total current assets		837,799			1,075,165
Long term assets:
Property and equipment, net		86,920			87,551
Other assets		59,376			55,444
Total assets	$	984,095		$	1,218,160
Liabilities and Shareholders' Equity
Liabilities:
Accounts payable and accrued liabilities	$	194,199		$	253,824
Deferred revenue		530			32,358
Lease payable		15,048			7,539
Other current liabilities		1,682			1,682
Total current liabilities		211,459			295,403
Total liabilities		211,459			295,403
Shareholders' equity:
Common stock, no par value, 500,000,000 shares authorized, 20,426,158 shares issued and outstanding at March 31, 2020 and December 31, 2019		-			-
Additional paid-in capital		6,533,615			6,517,885
Accumulated deficit		(5,760,979	)		(5,595,128	)
Total shareholders' equity		772,636			922,757
Total liabilities and shareholders' equity	$	984,095		$	1,218,160

The accompanying notes are an integral part of these unaudited consolidated financial statements.

3

McorpCX, Inc.

Consolidated Statements of Operations

(unaudited)

	Three Months Ended
	March 31,
	2020			2019
Revenue, net
Consulting services	$	637,425		$	965,913
Products and other		32,367			44,415
Total revenue, net		669,792			1,010,328
Cost of goods sold
Labor		215,495			258,152
Products and other		43,848			130,248
Total cost of goods sold		259,343			388,400
Gross profit		410,449			621,928
Expenses
Salaries and wages		278,912			293,710
Contract services		3,029			42,180
Other general and administrative		288,783			275,530
Total expenses		570,724			611,420
Net operating (loss) income		(160,275	)		10,508
Interest expense		-			(1,231	)
Other expense		(5,576	)		(4,500	)
Net (loss) income	$	(165,851	)	$	4,777
Net (loss) income per share-basic and diluted	$	(0.01	)	$	0.00
Weighted average common shares outstanding-basic and diluted		20,426,158			20,426,158

The accompanying notes are an integral part of these unaudited consolidated financial statements.

4

McorpCX, Inc.

Consolidated Statements of Changes in Shareholders’ Equity

(unaudited)

	Three Months Ended March 31, 2019
							Retained
					Additional		Earnings
	Common Stock				Paid in		(Accumulated
	Shares		Amount		Capital		Deficit)			Total
Balance at December 31. 2018		20,426,158	$	-	$	6,454,791	$	(4,834,173	)	$	1,620,618
Stock based compensation - stock options		-		-		15,558		-			15,558
Net income		-		-		-		4,777			4,777
Balance at March 31, 2019		20,426,158	$	-	$	6,470,349	$	(4,829,396	)	$	1,640,953

	Three Months Ended March 31, 2020
							Retained
					Additional		Earnings
	Common Stock				Paid in		(Accumulated
	Shares		Amount		Capital		Deficit)			Total
Balance at December 31. 2019		20,426,158	$	-	$	6,517,885	$	(5,595,128	)	$	922,757
Stock based compensation - stock options		-		-		15,730		-			15,730
Net loss		-		-		-		(165,851	)		(165,851	)
Balance at March 31, 2020		20,426,158	$	-	$	6,533,615	$	(5,760,979	)	$	772,636

The accompanying notes are an integral part of these unaudited consolidated financial statements.

5

McorpCX, Inc.

Consolidated Statements of Cash Flows

(unaudited)

	Three Months Ended March 31,
	2020			2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) income	$	(165,851	)	$	4,777
Adjustments to reconcile net (loss) income to net cash (used in) provided by operations:
Depreciation and amortization		631			50,148
Operating lease ROU asset amortization		13,955			-
Stock compensation expense		15,730			15,558
Changes in operating assets and liabilities:
Accounts receivable		86,979			(39,336	)
Other assets		3,813			9,273
Accounts payable and accrued liabilities		(59,625	)		101,004
Lease liability		(14,191	)		(5,225	)
Other current liabilities		-			146
Deferred revenue		(31,828	)		96,576
Net cash (used in) provided by operating activities		(150,387	)		232,921
Net cash used in investing activities		-			-
Net cash used in financing activities		-			-
(Decrease) increase in cash and cash equivalents		(150,387	)		232,921
Cash and cash equivalents, beginning of period		588,848			1,350,014
Cash and cash equivalents, end of period	$	438,461		$	1,582,935
Supplemental disclosure of cash flow information:
Interest paid	$	-		$	1,231
Initial recognition of ROU asset and lease liability	$	21,700		$	-
ROU asset and operating lease obligation recognized upon adoption of ASU 2016-02	$	-		$	34,164

The accompanying notes are an integral part of these unaudited consolidated financial statements.

6

MCORPCX, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2020

(unaudited)

Note 1: Organization and Basis of Presentation

McorpCX, Inc. (“we,” “us,” “our,” or the “Company””) was incorporated in the State of California on December 14, 2001. We are a customer experience (CX) management solutions company dedicated to helping organizations improve customer experiences, increase customer loyalty, reduce costs and increase revenue. The Company operated as The Innes Group, Inc., d/b/a MCorp Consulting until filing a Certificate of Amendment to the Articles of Incorporation renaming the Company Touchpoint Metrics, Inc., effective October 18, 2011. During Q1 2015, the Company filed a d/b/a (doing business as) with the State of California Secretary of State to begin doing business as McorpCX. On June 11, 2015, at our Annual General Meeting, shareholders passed a resolution to change the name of the Company to McorpCX, Inc.

The Company formed a wholly owned subsidiary, McorpCX, LLC (“McorpCX LLC”) as a limited liability company in the state of Delaware on December 14, 2017. On August 16, 2018, the Company entered into a contribution agreement with its wholly owned subsidiary McorpCX LLC, pursuant to which the Company transferred to McorpCX LLC all of the Company’s assets and liabilities related to the Company’s customer experience consulting business, excluding the underlying technology and databases related thereto which remained with the Company.

We are a customer experience services company, currently focused on delivering consulting and technology solutions to customer-centric organizations. We are engaged in the business of delivering consulting and professional services that are designed to help corporations improve their customer listening and customer experience management capabilities. To augment our consultative solutions, we have developed technology products that include on-demand “cloud based” customer experience management software. Our professional and related services include a range of customer experience management services such as research, training, strategy consulting and process optimization. 

On April 15, 2020, the Company entered into a definitive purchase agreement (the “Purchase Agreement”) to sell all of the membership interests in McorpCX, LLC to mfifty, LLC, a California limited liability company controlled by Michael Hinshaw, the current President of McorpCX, LLC (the “Purchaser”). The Purchase Agreement provides that as consideration for the sale of McorpCX, LLC, the Company will receive a total consideration of $1,108,000 consisting of $100,000 in cash received upon the signing of the Purchase Agreement and $252,000 in cash to be received at the closing of the transaction along with a $756,000 promissory note.

The transaction is expected to close in June 2020, subject to the approval of the majority of the outstanding shares of the Company held by disinterested shareholders. Upon completion of the sale of McorpCX, LLC, the Company intends on focus on growing the Company’s software development and technology services business.

The consolidated financial statements and related disclosures as of and for the three months ended March 31, 2020 and 2019, are unaudited, pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC"). The consolidated balance sheet as of December 31, 2019 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. In our opinion, these consolidated financial statements include all adjustments (consisting only of normal recurring adjustments) necessary for the fair statement of the results for the interim periods. These consolidated financial statements should be read in conjunction with the consolidated financial statements included in our Annual Report for the year ended December 31, 2019, filed on Form 10-K with the SEC on March 27, 2020.  The results of operations for the three months ended March 31, 2020, are not necessarily indicative of the results to be expected for the full year.

Note 2: Recent Accounting Pronouncements

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”), which contains practical expedients for reference rate reform related activities that impact debt, leases, derivatives and other contracts. The guidance in ASU 2020-04 is optional and may be elected over time as reference rate reform activities occur. We are currently evaluating the impact of the guidance and our options related to the practical expedients. We don’t expect the adoption of this standard to have a material impact on the consolidated financial statements.

7

Note 3. Revenues

Consulting Service Revenues

The Company’s consulting services are project based and include the articulation of customer-centric strategies and implementation roadmaps in support of these strategies. The performance obligation in these projects is the delivery of specific findings reports as it pertains to the analysis of a client customer’s experience. These projects include milestone payments for completion of different phases of the project and are included in the transaction price. These milestone payments are deemed to be fixed because the milestones are within the control of the Company. The projects also include reimbursable expenses, which are part of the transaction price and deemed variable consideration. These reimbursable expenses are estimated at contract inception. Given the confidentiality provisions in the agreement and the nature of the services being performed, the Company has no alternative use for the specific findings report. Therefore, the Company recognizes the transaction price over time, based on percentage of completion of the milestones in the contract.

Product and other revenue

Product and other revenue during 2020 and 2019 has primarily been derived from reimbursable expenses charged to clients. The product related portion of this revenue originates from the utilization of the Company’s web-hosted Touchpoint Mapping On-Demand application (“Touchpoint Mapping”), which is designed to gather customer satisfaction data, track brand perceptions, and analyze results. Touchpoint Mapping is a SaaS (Software as a Service) subscription-based technology application, which derives revenue from the following sources: nonrefundable setup fees, subscription fees, professional service fees, and consulting fees related to implementation, customization, configuration, training, and other value-added services. Customer licenses for Touchpoint Mapping are not subject to the licensing guidance in Topic 606 because the customer can’t take possession of the software at any time and the customer would not be able to operate the software on its own or with another third party. Fees charged to customers of Touchpoint Mapping may include implementation, setup, training and license fees for the application. Revenue generated from Touchpoint Mapping (either directly through licensing fees or fees received through support functions) is recognized on a straight-line basis because the Company’s obligations under its contracts concerning Touchpoint Mapping are deemed to be stand-ready obligations due to the fact that the Company is contractually required to provide access to Touchpoint Mapping and customer support on a daily basis. Consequently, usage of Touchpoint Mapping by customers does not affect the ability of customers to access the application or our customer support functions. For these reasons, revenue is recognized on a straight-line basis over the contract period. If billings are front loaded, this will result in a deferral of revenue during the contract period. For recognition purposes, we do not unbundle such services into separate performance obligations as their pattern of transfer does not differ.

Deferred Revenues (Contract Liabilities)

The Company records deferred revenues when cash payments are received, including amounts which are refundable.

Payment terms vary by customer and the products or services offered. The term between invoicing and when payment is due is not significant. For certain products or services and customer types, full or a partial payment of the entire contract is required before the products or services are delivered to the customer.

The aggregate amount of the fees received from customers that are allocated to each customer’s respective performance obligation that is unsatisfied (or partially unsatisfied) is $530 as of March 31, 2020 and included in deferred revenue on the accompanying consolidated balance sheets. The Company expects to recognize revenue of $530 in 2020 related to these unsatisfied (or partially unsatisfied) performance obligations. Deferred revenue is not expected to be recognized beyond fiscal year 2021. 

During the three months ended March 31, 2020 and 2019, we recognized revenue of $31,828 and $75,105, related to our contract liabilities included in deferred revenue at December 31, 2019 and 2018, respectively.

Practical Expedients and Exemptions

Contract costs consist primarily of sales commissions. The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less and the commissions are only due and payable upon receipt of payment from the client. These costs are recorded within sales and marketing expenses.

The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.

8

Note 4: Stock-Based Compensation

Our stock-based compensation plan was originally established in 2008. The shares of our common stock issuable pursuant to the terms of such plan (the “Plan Shares”) could not exceed 30% of any outstanding issue or 2,500,000 shares, whichever was the lower amount.

In December 2015, we adopted a revised share option plan in which Plan Shares cannot exceed 10% of the total issued and outstanding shares at any given time. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of the grant and all option grants have a 10-year term. This share option plan was initially approved by the Company’s shareholders at the annual meeting of shareholders on August 10, 2016 and has subsequently been re-approved at each subsequent annual meeting of the Company’s stock holders since that date, as required under applicable TSX-V rules.

To calculate the fair value of stock options at the date of grant, we use the Black-Scholes option pricing model. The volatility used is based on a blended historical volatility of our own stock and similar sized companies due to the limited historical data available for our own stock price. The expected term was determined based on the simplified method outlined in Staff Accounting Bulletin No. 110. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

The following table summarizes our stock option activity for the three months ended March 31, 2020:

					Weighted
			Weighted		Average
			Average		Remaining		Aggregate
	Number of		Exercise		Contractual		Intrinsic
	Shares		Price		Term (in years)		Value
Outstanding at December 31, 2019		1,140,000	$	0.35		6.25		-
Granted		-		-		-		-
Exercised		-		-		-		-
Cancelled		-		-		-		-
Forfeited or expired		-		-		-		-
Outstanding at March 31, 2020		1,140,000	$	0.35		6.00		-
Exercisable at March 31, 2020		680,000	$	0.43		4.39	$	-

At March 31, 2020, 680,000 stock options were exercisable and $15,730 of total compensation cost related to share-based compensation grants had been recognized for the three months ended March 31, 2020. Unrecognized compensation expense from stock options was $86,776 at March 31, 2020, which is expected to be recognized over a weighted-average vesting period of 1.38 years beginning April 1, 2020.

There were no options granted during the three months ended March 31, 2020.

A summary of the status of the Company’s nonvested options as of March 31, 2020, is presented below:

Nonvested options
	Number of
	Shares
Nonvested options at December 31, 2019		460,000
Granted		-
Exercised		-
Cancelled		-
Forfeited or expired		-
Vested		-
Nonvested options at March 31, 2020		460,000

9

Note 5: Concentrations 

We sell products and services under various terms to a broad range of companies across multiple industries ranging from start-ups to Fortune 500 companies, with sales historically concentrated among a few large clients. We continue to make efforts to mitigate risk from loss of a single client and shift sales concentration to a more even distribution among our clients. For the three months ended March 31, 2020 and 2019, the percentage of sales and the concentrations are:

	2020			2019
Largest client		25	%		35	%
Second largest client		22	%		16	%
Third largest client		20	%		15	%
Next three largest clients		28	%		26	%
All other clients		5	%		8	%
		100	%		100	%

Sales are made without collateral and the credit-related losses have been insignificant or non-existent. Accordingly, there is no provision made to include an allowance for doubtful accounts.

Note 6: Leases

In 2019, the Company adopted the provisions of Accounting Standards Update 2016-02, Leases, effective January 1, 2019. We determined if an arrangement is a lease at inception. Operating lease right-of-use (“ROU”) assets are recorded in other assets and operating lease liabilities are recorded in current liabilities in the accompanying consolidated balance sheets. Finance leases, none of which existed as of the adoption of Accounting Standards Codification (“ASC”) 842 or as of December 31, 2019, would be reflected in property and equipment and other liabilities in our consolidated balance sheets.

ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

Under the available practical expedient, we account for the lease and non-lease components as a single lease component for all classes of underlying assets. Further, we elected a short-term lease exception policy on all classes of underlying assets, permitting us to not apply the recognition requirements of this standard to short-term leases (i.e. leases with terms of 12 months or less). 

Effective January 1, 2020, the Company’s leased office space in San Anselmo, California which was originally scheduled to expire on March 31, 2020 was renegotiated and treated as a modified lease for a 6-month term and monthly rent of $2,539 and will expire September 30, 2020. As of January 1, 2020, the impact of the modified lease with a discount rate of 6% resulted in the recognition of a right of use asset of $21,700, included in other assets, and lease payable obligation on the Company’s consolidated balance sheets of $22,405. Lease expense was $13,955 and $6,833 for the three months ended March 31, 2020 and 2019, respectively, which is included in the general and administrative expense in the accompanying consolidated statements of operations.

Note 7: Going Concern

The accompanying consolidated financial statements and notes have been prepared assuming that the Company will continue as a going concern.

We have had material operating losses and have not yet created positive cash flows for a full fiscal year. These factors raise substantial doubt as to our ability to continue as a going concern. We continue to focus on our sales pipeline of new business and our cost reduction plans to improve upon our positive working capital of $626,340 at March 31, 2020.  On April 15, 2020, McorpCX, Inc., (the "Company") entered into the Purchase Agreement to sell all of the membership interests in McorpCX, LLC, of which the proceeds of $1,108,000, consisting of $352,000 in cash and a $756,000 promissory note, are expected to be applied to transaction costs as well as investment toward becoming a technology services business. See Note 9 for details. These measures combined with our positive working capital position should enable us to meet our liquidity needs over the next 12 months. Notwithstanding the foregoing, our longer-term ability to continue as a going concern is entirely dependent upon our ability to achieve a level of profitability, and/or to raise additional capital through debt financing and/or through sales of common stock. We cannot provide any assurance that profits from operations, if any, will generate sufficient cash flow to meet our working capital needs and service our existing obligations, nor that sufficient capital can be raised through debt or equity financing. The consolidated financial statements do not include adjustments related to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should we be unable to continue as a going concern.

10

Note 8: Basic and Diluted Net Income / (Loss) per Share

Net income (loss) per share was computed by dividing the net income (loss) by the weighted average number of common shares outstanding during the period. The weighted average number of shares was calculated by taking the number of shares outstanding and weighting them by the amount of time that they were outstanding. For the three months ended March 31, 2020 and 2019, the assumed exercise of share options is anti-dilutive and are excluded from the determination of net income (loss) per share – basic and diluted. The share options were anti-dilutive due to the Company’s net loss or the Company’s common stock average market price was less than the share options exercise price. Accordingly, net (loss) / income per share basic and diluted are equal in all periods presented. Securities that were not included in the diluted per share calculations because they would be anti-dilutive were options to purchase common stock of 680,000 and 1,350,000 for the three months ended March 31, 2020 and 2019, respectively.

	Three Months Ended
	March 31,
	2020			2019
Net (loss) income	$	(165,851	)	$	4,777
Basic and diluted weighted average common shares outstanding		20,426,158			20,426,158
Net (loss) income per share, basic and diluted	$	(0.01	)	$	0.00

Note 9: Subsequent Events

On April 15, 2020, the Company entered into the Purchase Agreement to sell all of the membership interests in McorpCX, LLC, to the Purchaser. Since the Company’s professional and related consulting services business, which currently constitutes substantially all of the Company’s operations, is conducted through McorpCX, LLC, the sale of McorpCX, LLC constitutes the sale of substantially all of the Company’s assets under the California Corporations Code, and as such, the Company will be seeking stockholder approval of the Purchase Agreement.

The Purchase Agreement provides that as consideration for the sale of McorpCX, LLC, the Company will receive a total of $352,000 in cash consisting of $100,000 received upon the signing of the Purchase Agreement and $252,000 to be received at the closing of the transaction along with a $756,000 promissory note. The promissory note has an initial annual interest rate of 0.99% (to be recalculated at the end of each twelve month period subsequent to the date of the note based on the annual Applicable Federal Rate for mid-term loans on the first business day following each such twelve month period) accruing daily on the outstanding balance of the note, and monthly principal payments are to be payable to the Company over a term of four or more years. Monthly principal payments to the Company are initially $7,292 per month for the first twelve months following the date of the note, and then during each subsequent twelve month period are to be based on the annual revenues of McorpCX, LLC.

The sale of McorpCX, LLC is subject to the approval of the Purchase Agreement by the majority of the outstanding shares of the Company held by disinterested shareholders, the approval of the TSX Venture Exchange, the sale of all of the Company’s shares of common stock currently owed by Mr. Hinshaw to third parties on terms reasonably satisfactory to the Company, and the satisfaction of customary closing conditions.

The transaction is expected to close in June 2020, subject to the approval of the majority of the outstanding shares of the Company held by disinterested shareholders.

On May 12, 2020, the Company received an unsecured non-recourse promissory note in the amount of $161,169 under the Paycheck Protection Program. In March 2020, the Coronavirus Aid, Relief, and Economic Security Act was passed in the United States, which included amongst other programs, loans to businesses under a Paycheck Protection Program. The Paycheck Protection Program Note incurs interest at a fixed rate of 1.00% and is schedule to mature on May 3, 2022. The Company is required to make monthly payments on the note of $6,785 commencing on November 1, 2020.

11

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Cautionary Statement

This Management’s Discussion and Analysis includes a number of forward-looking statements that reflect our current views with respect to future events and financial performance. Forward-looking statements are often identified by words like: “believe,” “expect,” “plan”, “estimate,” “anticipate,” “intend,” “project,” “will,” “predicts,” “seeks,” “may,” “would,” “could,” “potential,” “continue,” “ongoing,” “should” and similar expressions, or words which, by their nature, refer to future events. You should not place undue certainty on these forward-looking statements, which apply only as of the date of this Form 10-Q. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or from our predictions. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events, or otherwise.

Unless the context otherwise requires, all references to "McorpCX," "we," "us," "our" or the "Company" are to McorpCX, Inc. and our subsidiaries.

Critical Accounting Policies and Estimates

Our financial statements are prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results could differ from these estimates. We believe that the assumptions and estimates associated with revenue recognition, income taxes, stock-based compensation, research and development costs and impairment of long-lived assets have the greatest potential impact on our financial statements. Therefore, we consider these to be our critical accounting policies and estimates.

A description of the Company’s critical accounting policies and related judgments and estimates that affect the preparation of the Company’s financial statements is set forth in under the heading “Critical Accounting Policies and Estimates” in Item 7, Management’s Discussion and Analysis of the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. With the exception of the policy adoptions discussed in Note 2 of the Notes to the Consolidated Financial Statements included with this report, such policies were unchanged during the three months ended March 31, 2020.

Overview

We are a customer experience (CX) management solutions company dedicated to helping organizations improve customer experiences, increase customer loyalty, reduce costs and increase revenue. We believe that delivering better customer experiences is a powerful, sustainable way for any organization to differentiate themselves from their competition. As such, we are engaged in the business of providing customer experience focused consulting services and where applicable, delivering technology-enabled services that are designed to help corporations improve their customer listening and customer experience management capabilities with the goal of helping them design and deliver better experiences for their customers.

Our primary source of revenue is derived from our consulting services which are intended to help primarily large and medium sized organizations plan, design and deliver better customer experiences in order to maximize their return on investment, improve efficiency, and increase the adoption of our products and services. Our services offered include a range of customer experience management consulting services in the areas of research, strategy development, planning, education, training and best practices, as well as providing customer-centric strategies and implementation roadmaps in support of these strategies.

We have developed on-demand “cloud based” customer experience management software such as Touchpoint Mapping® On-Demand (also marketed as McorpCX | Insights), referred to as “Touchpoint Mapping”, and McorpCX | Persona.

Touchpoint Mapping is a research-based online Software-as-a-Service (“SaaS”) solution designed to provide insights to organizations that can help them improve customer and employee experience, brand, and loyalty. It is designed to be a solution for customer-centric organizations to measure and gather customer data across all their touchpoints, channels and interactions with their customers.

McorpCX | Persona, another online SaaS solution, is designed for developing and managing customer persona, as well as automating the currently manual process of developing, managing and sharing persona across corporations. It is designed to help customer-centric businesses and the agencies and consultancies that serve them to better understand, connect with and serve their customers.

There are many potential unforeseen and significant market and competitive risks associated with our current products and services. Though we released the first version of Touchpoint Mapping in 2013, and we released the first version of McorpCX | Persona in 2016, neither product has generated significant sales revenue to date, and we cannot predict the timing or probability of generating material sales revenue from either of them. Further, as of the date of this report, we have yet to engage the necessary development, client support, and sales staff required to identify, develop, and close material product sales opportunities that we believe are required to achieve our product sales and revenue growth objectives. We also believe that our current software capabilities are more limited in scope than our desired final software platform and as such, significant further software development expenditures will be required. Revenues from our consulting services provided to our clients represented a majority of our revenue in 2019 and all revenues for the three months ended March 31, 2020.

12

In addition, in December 2019, a novel strain of coronavirus (“COVID-19”) was reported in Wuhan, China and has since extensively impacted the global health and economic environment. In March 2020, the World Health Organization characterized COVID-19 as a pandemic. Although the financial impacts of COVID-19 to the Company’s current quarter have been limited due to the timing of onset, the COVID-19 pandemic and the government responses to the outbreak presents uncertainty and risk with respect to the Company and its performance and financial results.

The Company has taken steps, and will continue to take further actions, in its approach to minimizing the impact of the COVID-19 pandemic on its business. With the exception of key operations personnel, we have shifted our office staff to remote workstations, and we expect we will continue to operate remotely until state and local government shelter-in-place orders have been lifted and management determines it is safe for employees to return to offices. The Company has also implemented cost containment strategies across all areas of the organization, including curtailment of Company travel and salary reductions for its senior management and certain employees. In March 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was passed in the United States, which included amongst other programs, loans to businesses under a Paycheck Protection Program (“PPP”). On May 12, 2020, the Company received an unsecured non-recourse promissory note in the amount of $161,169 under the PPP (the “PPP Note”). The PPP Note incurs interest at a fixed rate of 1.00% and is schedule to mature on May 3, 2022. The Company is required to make monthly payments on the PPP Note of $6,785.42 commencing on November 1, 2020.

The extent of the impact of the COVID-19 pandemic on the Company's business is highly uncertain and difficult to predict, as the response to the pandemic is in its early stages and information is rapidly evolving. The severity of the impact of the COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on the Company's customers, all of which are uncertain and cannot be predicted.

The Company is in the process of determining the optimal path forward for our software products based on current market dynamics, the competitive environment and customer feedback. We continue to evaluate various potential strategies with the goal of improving our ability to achieve additional revenue and profit growth for software products. These possible strategies, which are generally focused on ways to create a more complete slate of customer experience solutions for potential clients, include further software or technology development expenditures, pursuit of merger, acquisitions or joint ventures with companies that provide complimentary products and services, software licensing arrangements, and investment in additional infrastructure within our Company. Each of these possible strategies will be thoroughly vetted by our board of directors to assess the expected level of enterprise value creation for each strategy compared to the various risks associated with each possible scenario. In addition, we may require financing to pursue these strategies that is beyond our current financial resources. Accordingly, there is no assurance that we will be able to pursue any strategies that are identified by our board of directors.

On April 15, 2020, the Company entered into a definitive purchase agreement (the “Purchase Agreement”) to sell all of the membership interests in its wholly-owned subsidiary, McorpCX, LLC, for total consideration of $1,108,000 consisting of $100,000 received upon the signing of the Purchase Agreement and $252,000 to be received at the closing of the transaction along with a $756,000 promissory note. The transaction is expected to close in June 2020, subject to the approval of the majority of the outstanding shares of the Company held by disinterested shareholders. Upon completion of the sale of McorpCX, LLC, the Company intends on focus on growing the Company’s software development and technology services business.

We cannot assure you that we will be able to complete the any of the transactions outlined in the Purchase Agreement, execute on our strategy of developing our software development or technology services business, or otherwise compete successfully against current or potential competitors, or that competition will not have a material adverse effect on our business, financial condition and operations. 

Summary of Financial Results

Select financial highlights for the three months ended March 31, 2020:

● Total revenue decreased by 34% from $1,010,328 during the first quarter of 2019 to $669,792 during the first quarter of 2020.

● Gross profit decreased by 34% from $621,928 in the first quarter of 2019 to $410,449, in the first quarter of 2020.

● We recorded net loss of $165,851 in the first quarter of 2020, compared to net income of $4,777 for the first quarter of 2019.

● The Company reported EBITDA⁽¹⁾ of $(165,220) in the first quarter of 2020, compared to an EBITDA of  $56,156 in the first quarter of 2019.

● The Company had a cash balance of $438,461 at March 31, 2020 compared to a cash balance of $588,848 at December 31, 2019.

⁽¹⁾ We define EBITDA as net income (loss) plus interest, tax, depreciation and amortization expenses. We consider EBITDA to be a meaningful supplement to net income (loss) as a performance measure primarily because depreciation and amortization expenses are not actual cash costs, and interest and tax expenses are not related to our direct operating activities. See page 15 for a reconciliation of net income (loss) to EBITDA.

13

Sources of Revenue

Our revenue consists primarily of fees from professional and consulting services and other revenue primarily related to the reimbursement of expenses entirely through the operations of McopCX LLC. Through May 31 of last year, revenue was also derived from the Company’s software-enabled product sales. Consulting services include customer experience management consulting in the areas of strategy development, planning, education, training and program design, and includes the articulation of customer-centric strategies and implementation roadmaps in support of these strategies, while other revenue includes reimbursement of related travel costs and out-of-pocket expenses. Product revenue was from productized and software-enabled service sales not elsewhere classified.

The consulting services are contracted under master terms and conditions with statements of work (“SOW”) defined for each project. A typical consulting SOW will span a period of 60-180 days and will usually be billed to the client based on certain milestones being achieved throughout the SOW. The Company recognizes revenue based upon a percentage of completion of each SOW during each project. In addition, we typically incur travel and other miscellaneous expenses during work on each SOW which we bill to our clients for reimbursement. The travel and miscellaneous expenses are recognized in revenue on a percentage of work complete basis.

During the second half of 2017, we stopped further development of our software products and in 2018 we suspended actively selling Touchpoint Mapping and McorpCX | Persona in order to re-assess the product roadmap to better define the future direction of our software platform. On May 31, 2019, the last remaining contract for Touchpoint Mapping was closed, and we believe no further revenue will be recognized from this date, unless we decide to further develop, upgrade and provide support to resume actively selling our software products and obtain material stand-alone sales commitments for them.

When we were actively selling the products, we found that the implementation stage of on-demand software and software-enabled services engagements (the time between a client placing an order to the live deployment of our product ordered) averaged between 30 and 45 days. We typically invoiced clients upon inception of subscription agreements for setup and total subscription fees contracted over the term of the agreements, with payment due within 30 days. We then recognized the subscription fee revenue, including any associated professional services or separate set-up fee revenue, on a straight-line basis over the life of the agreement.

Subscription agreements for our software solutions had been offered as monthly term agreements which contain a minimum commitment period of at least 12 months, and which have included related setup, upgrades, hosting and support. Professional services have included consulting fees related to implementation, customization, configuration, training and other services.

Professional services related to the subscription agreements are invoiced at the inception of the professional services agreement at a negotiated percentage of total fees, often but not exclusively one-third or one-half of the total estimated professional services fees, with the balance of payments due over the duration of the contract as project milestones are met. Amounts invoiced are recorded in accounts receivable and deferred revenue or revenue, depending on whether revenue recognition criteria have been met.

Cost of Goods Sold and General and Administrative Expenses

Cost of Goods Sold

Cost of goods sold has historically consisted primarily of expenses directly related to providing professional and consulting services. Those expenses include contract labor, third-party services, and materials and travel expenses related to providing professional services to our clients. Costs of goods also includes, but is not limited to, product-related hosting and monitoring costs, the cost of licenses for products embedded in the application, amortization of capitalized software development costs, service support costs, and costs related to account and subscription management, as applicable.

General and Administrative Expenses

General and administrative expenses consist primarily of salary and related expenses for management, client delivery, finance and accounting, and sales and marketing. These expenses also include contract services, as well as marketing and promotion costs, professional fees, software license fee expenses, administrative costs, insurance, rent and a portion of travel expenses and other overhead, which are categorized as “other general and administrative expenses” in our consolidated financial statements. In addition, the other general and administrative expenses include the professional fees, filing, and registration costs necessary to meet the requirements associated with having to file reports with the United States Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as well as having our stock listed on the TSX Venture Exchange in Canada and quoted on the OTCQB venture marketplace in the United States.

Sales and marketing expenses are currently reflected in salaries and wages, commissions, contract labor, sales, marketing and promotion, and other related overhead expense categories. Since we currently recognize revenue over the term of the consulting and professional services engagements or any software subscriptions, we expect to experience a delay between increases in selling and marketing expenses and the recognition of revenue.

14

Results of Operations

					Change from			Percent Change
Revenue	2020		2019		Prior Year			from Prior Year
Three Months Ended March 31,	$	669,792	$	1,010,328	$	(340,536	)		(34%	)

Overall, the 34% decrease in revenue was attributed to a 34% decrease in consulting services revenue and a 27% decrease in products and other revenue in the three months ended March 31, 2020 compared to the same period in the prior year. The decrease in consulting services revenue from $965,913 in 2019 to $637,425 in 2020 was primarily the result of the loss of a major client account. The decrease in product and other revenue from $44,415 for the three months ended March 31, 2019 to $32,367 for the same period in 2020, was primarily the result of our decision to suspend selling each of our software products in 2019 combined with a decrease in reimbursable expense mostly resulting from less travel required to execute the projects in the first quarter of 2020 compared to the same period in 2019.

					Change from			Percent Change
Cost of Goods Sold	2020		2019		Prior Year			from Prior Year
Three Months Ended March 31,	$	259,343	$	388,400	$	(129,057	)		(33%	)

Cost of goods sold decreased by $129,057, for the three months ended March 31, 2020, compared to the same period in 2019 primarily as a result of a 17% decrease in professional fees and an 84% decrease in non-reimbursable expenses. The decrease in professional fees from $258,152 in 2019 to $215,495 for 2020 was primarily the result of a decrease in billings from our contract consultants mostly due to less consulting revenue volume described above. The decrease in non-reimbursable expenses from $31,750 in 2019 to $5,196 for 2020 was primarily the result of new contracts being structured to allow for more reimbursable expenses in 2020 compared to contracts in the same period in 2019 that did not allow for reimbursable expenses. The remainder of the decrease in cost of goods sold in the first quarter of 2020 compared to the first quarter of 2019 was mostly attributable to a decrease in amortization of capitalized software development costs as well as a reduction in vendor and reimbursable expenses in the first three months of 2020 compared to the same period in the prior year.

						Change from			Percent Change
Net Operating Income (Loss)	2020			2019		Prior Year			from Prior Year
Three Months Ended March 31,	$	(160,275	)	$	10,508	$	(170,783	)		(1,625%	)

For the three months ended March 31, 2020 we had net operating loss of $160,275 compared to a net operating income of $10,508 for the three months ended March 31, 2019. The decrease in net operating income in the current quarter was primarily a result of decreased total revenues, and an increase in general and administrative costs being partially offset by decrease in costs of goods sold when compared to the same period in 2019.

15

EBITDA decreased by $221,376 to a loss of $165,220 for the three months ended March 31, 2020 to earnings of $56,156 for the three months ended March 31, 2019. 

We consider EBITDA to be a meaningful supplement to net income (loss) as a performance measure primarily because depreciation and amortization expenses are not an actual cash costs, and interest and tax expenses are not related to our direct operating activities. In addition, we believe EBITDA is commonly used by investors and other interested parties to evaluate our financial performance. EBITDA does not reflect the impact of a number of items that affect our net income (loss), including financing costs. EBITDA should not be considered as an alternative to net income (loss) or income (loss) from operations as a measure of performance, or as an alternative to net cash from operating activities as a measure of liquidity. EBITDA is an internal measure and therefore may not be comparable to other companies. EBITDA has significant limitations as an analytical tool, and should not be considered in isolation, or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are that EBITDA does not reflect: (i) our cash expenditures, or future requirements, for capital expenditures or contractual commitments; (ii) changes in, or cash requirements for, working capital needs; and (iii) the interest expense, or the cash requirements necessary to service interest or principal payments, on our outstanding debt (if any). Because of these limitations, EBITDA should only be considered as a supplemental performance measure and should not be considered as a measure of liquidity or cash available to us to invest in the growth of our business. Because all companies do not calculate EBITDA in the same manner, EBITDA as calculated by us may differ from EBITDA as calculated by other companies. We compensate for these limitations by using EBITDA as a supplemental measure of our performance and by relying primarily on our GAAP consolidated financial statements.

The following table provides a reconciliation of net income (loss) to EBITDA for the periods indicated:

	Three Months Ended
	March 31,
	2020			2019
Net (Loss) Income	$	(165,851	)	$	4,777
Depreciation and Amortization		631			50,148
Interest expense		-			1,231
EBITDA	$	(165,220	)	$	56,156

					Change from			Percent Change
Salaries and Wages	2020		2019		Prior Year			from Prior Year
Three Months Ended March 31,	$	278,912	$	293,710	$	(14,798	)		(5%	)

Salaries and wages decreased by $14,798 during the three months ended March 31, 2020 compared to the same period in 2019 primarily due to a decrease in the compensation of our executives officers in the current quarter compared to the same quarter in 2019.

					Change from			Percent Change
Contract Services	2020		2019		Prior Year			from Prior Year
Three Months Ended March 31,	$	3,029	$	42,180	$	(39,151	)		(93%	)

Expenses related to contract services decreased in the first quarter of 2020 compared to the same quarter in 2019 primarily due to finance and administration services provided by contractors in the first three months of 2019, which were not required in the first three months of 2020.

					Change from		Percent Change
Other General and Administrative	2020		2019		Prior Year		from Prior Year
Three Months Ended March 31,	$	288,783	$	275,530	$	13,253		5	%

Other general and administrative costs increased $13,253 during the three months ended March 31, 2020 compared to the same period in 2019, primarily due to increases in professional fees, insurance, dues and subscriptions, and rent partially offset by decreases in sales, marketing and promotion expenses as well as travel, meals, and entertainment.

							Change from			Percent Change
Other Income/Expense	2020			2019			Prior Year			from Prior Year
Three Months Ended March 31,	$	(5,576	)	$	(4,500	)	$	(1,076	)		24	%

Other expense increased for the three months ended March 31, 2020 compared to the first quarter of 2019, primarily due to increased state use tax expenses.

16

Liquidity and Capital Resources

We measure our liquidity in a variety of ways, including the following:

	March 31,		December 31,
	2020		2019
Cash and cash equivalents	$	438,461	$	588,848
Working capital	$	626,340	$	779,762

Anticipated Uses of Cash

As of March 31, 2020, our cash and cash equivalents and working capital had decreased to $438,461 and $626,340, respectively, from $588,848 and $779,762 as of December 31, 2019. The decrease in cash during the first quarter of 2020 was primarily the result of a net loss of $165,851 combined with a decrease in accounts payable during the first three months of 2020.

For the three months ended March 31, 2020 and the year ended December 31, 2019, we were able to finance our operations with cash generated through operating activities, and cash on hand. The accompanying consolidated financial statements have been prepared in accordance with GAAP applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.

During the three months ended March 31, 2020, our primary uses of cash included cash paid to professional staff to support our consulting services, general and administrative support and new business development activities.

We currently plan to fund our expenditures with cash flows generated from ongoing operations, or new revenue sources, and/or if needed, the possibility may exist to raise additional capital through debt financing and/or through sales of common stock. We do not intend to pay dividends in the foreseeable future. Based upon the current level of our pipeline of signed contracts and pipeline of potential new projects plus our current expectations for future periods in light of the current economic environment, we believe that cash flow from operations and available cash will be adequate to finance the capital requirements for our business during the next 12 months.

The Company entered into Purchase Agreement on April 15, 2020, and assuming the closing conditions are either met or properly waived, expects to receive total consideration of $1,108,000 consisting of $352,000 in cash and a $756,000 promissory note for the sale of McorpCX, LLC.

In addition to the transactions contemplated in the Purchase Agreement, we intend to continue to seek ways to expand upon our business and as such, in the future we may make acquisitions of businesses or assets or commitments to additional capital projects. To achieve the long-term goals of expanding our assets and earnings, including through acquisitions, capital resources may be required. Depending on the size of a transaction, the capital resources that may be required can be substantial. The necessary resources may be generated from cash flow from operations, cash on hand, the proceeds of the sale of McorpCX, LLC, borrowing against our assets or the issuance of securities, and there is no assurance these capital resources will be available to us when required.

Cash Flow – Three months ended March 31, 2020 and 2019

Operating Activities. Net cash used in operating activities increased to $150,387 for the three months ended March 31, 2020 compared to net cash provided by operating activities of $232,921 for the three months ended March 31, 2019. This increase in cash used in 2020 was primarily due to decreased accounts payable and accrued liabilities, combined with a net loss of $165,851 in the first three months of 2020.

Days Sales Outstanding (“DSO”), which the Company defines as the average number of days it takes to collect revenue once a sale has been made, increased in the first three months of 2020 compared to the same period of the prior year. During the three months ended March 31, 2020, DSO was approximately 57 days, up from approximately 34 days during three months ended March 31, 2019. This increase was largely attributed to the decrease in sales during the current period. DSO can fluctuate due to the timing and nature of contracts that lead to up-front billings related to deferred revenue on services not yet performed.

Investing Activities. There was no cash provided by, or used in, investing activities for three months ended March 31, 2020 and 2019.

Financing Activities. There was no cash provided by, or used in, financing activities for the three months ended March 31, 2020 and 2019.

Off Balance Sheet Arrangements

We did not have any off-balance sheet arrangements as of March 31, 2020.

17

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and as such, are not required to provide the associated information under this item.

ITEM 4. CONTROLS AND PROCEDURES.

Disclosure Controls and Procedure

Pursuant to Rule 13a-15(b) and Rule 15d-15(b) under the Exchange Act, the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the Company’s disclosure controls and procedures (as defined under Rule 13a-15(e) or Rule 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, the Company’s management concluded that, as of the period covered by this report, and as reported in Item 9A of the Company’s Fiscal 2019 Form 10-K, the Company’s disclosure controls and procedures were not effective to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management to allow timely decisions regarding required disclosure.

It should be noted that any system of controls is based in part upon certain assumptions designed to obtain reasonable (and not absolute) assurance as to its effectiveness, and there can be no assurance that any design will succeed in achieving its stated goals.

Changes in Internal Controls

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

We are not involved in any legal actions or claims and to our knowledge no such actions or claims are pending.

ITEM 1A. RISK FACTORS.

In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (the “2019 Annual Report”), which could materially affect our business, results of operations or financial condition. In addition to the risks outlined in the 2019 Annual Report we are subject to the following risks:

The COVID-19 pandemic could adversely affect our financial results, operations and outlook for an extended period of time.

The COVID-19 pandemic and restrictions imposed by federal, state and local governments in response to the outbreak have disrupted and will continue to disrupt our business. We expect the stay-at-home orders and the sudden increase in unemployment caused by the closure of businesses in response to the COVID-19 pandemic to adversely affect our revenues, which adversely impacts our liquidity, financial condition and results of operations.

Our operations could be further disrupted if any of our executives or employees are unable or unwilling to work, whether because of illness, quarantine, restrictions on travel or fear of contracting COVID-19, which could further materially adversely affect our liquidity, financial position and results of operations.

We cannot predict how long the COVID-19 pandemic will last or if it will recur, if new government restrictions and mandates will be imposed or how long they will be effective, or the economic impact of such restrictions on our clients, so we cannot predict how long our results of operations and financial performance will be adversely impacted.

While the LLC Sale Transaction is pending, it creates uncertainty about the Company’s future that could have a material adverse effect the Company’s our business, financial condition and results of operations.

While the transaction to sell McorpCX, LLC pursuant to the terms of the Purchase Agreement (the “LLC Sale Transaction”) is pending, it creates uncertainty about the Company’s future. As a result of this uncertainty, the Company’s current or potential business partners and clients may decide to delay, defer or cancel entering into new business arrangements with the Company pending closing or termination of the LLC Sale Transaction. In addition, while the LLC Sale Transaction is pending, the Company is subject to a number of risks, including:

☐ the diversion of management and employee attention from our day-to-day business;

☐ the potential disruption to business partners and clients; and

☐ the possible inability to respond effectively to competitive pressures, industry developments and future opportunities.

The occurrence of any of these events individually or in combination could have a material adverse effect on the Company’s business, financial condition and results of operation.

18

You are not guaranteed any of the proceeds from the LLC Sale Transaction.

The consideration for McorpCX, LLC is expected to be paid by the Purchaser directly to the Company. The Company could spend or invest the net proceeds from the LLC Sale Transaction in ways with which our stockholders may not agree. The investment of these proceeds may not yield a favorable return.

The Company will be a very small public company.

Once the LLC Sale Transaction is completed, the Company is expected to continue to file periodic annual, quarterly and current reports, as well as proxy statements with the SEC. As a result, the Company will continue to incur additional ongoing operating expenses and the Company cannot assure how much of the cash proceeds, if any, will ultimately be distributed to stockholders or invested in growing the Company’s technology services business.

The Company’s ability to execute its strategy following the LLC Sale Transaction depends on the Company’s ability to retain and recruit qualified management and/or advisors.

The Company’s ability to execute its strategy following the closing of the LLC Sale Transaction requires that the Company retain and recruit personnel with technology services experience. There are no assurances that the Company will be able to find and/or be able to recruit qualified personnel required to build the Company’s technology services business, and if the Company is not able to recruit such personnel the Company may not be able to successfully grow its technology services business and consequently may not develop a revenue generating business after the completion of the LLC Sale Transaction.

Following the LLC Sale Transaction, the Company’s profitability and growth will depend on the success of the Company’s planned development of its technology services business, which is subject to a variety of business risks and uncertainties.

After completion of the LLC Sale Transaction, the Company is expected to be focused on growing its technology services business. Any evaluation of our technology services business and our prospects following the LLC Sale Transaction must be considered in light of the risks and uncertainties stated above, as well as the following:

☐ the ability to maintain our relationships with our existing clients;

☐ the ability to attract new clients; and

☐ potential capital costs used for investment in the technology services business;

If the Company is unable to address these risks, the Company’s business, results of operations and prospects following the closing of the LLC Sale Transaction could suffer and the company may not be able to successfully able to develop a revenue generating business.

The Company will incur significant expenses in connection with the LLC Sale Transaction, regardless of whether the LLC Sale Transaction is completed.

The Company expects to incur significant expenses related to the LLC Sale Transaction. These expenses include, but are not limited to, financial advisory fees and expenses, legal fees, accounting fees and expenses, filing fees, printing expenses and other related fees and expenses. Many of these expenses will be payable by the Company regardless of whether the LLC Sale Transaction is completed.

If the Company fails to complete the LLC Sale Transaction, the Company’s business may be harmed.

The Company cannot assure you that the LLC Sale Transaction will be completed. The closing of the LLC Sale Transaction is subject to the satisfaction of a number of conditions, including, among others, the requirement that stockholders adopt the LLC Sale Proposal and that the Company receives approval of the TSX Venture Exchange. The Company cannot guarantee that it will be able to meet all of the closing conditions in the Purchase Agreement. The Company also cannot be sure that other circumstances will not arise that would allow the Purchaser to terminate the Purchase Agreement prior to the closing of the LLC Sale Transaction. If the LLC Sale Transaction does not close, the Company’s Board of Directors will be forced to evaluate other alternatives, which may be less favorable to the Company than the proposed LLC Sale Transaction.

In addition, if the LLC Sale Transaction is not consummated, the Company’s directors, executive officers and other employees will have expended extensive time and effort and will have experienced significant distractions from their work during the pendency of the LLC Sale Transaction and the Company will have incurred significant transaction costs, in each case, without any commensurate benefit, which may have a material and adverse effect on the Company’s stock price and results of operations.

19

If the proposed LLC Sale Transaction is not completed, the Company may explore other potential transactions, but alternatives may be less favorable to us.

If the proposed LLC Sale Transaction is not completed, the Company may explore other strategic alternatives. An alternative transaction may have terms that are less favorable to the Company than the terms of the proposed LLC Sale Transaction, or the Company may be unable to reach agreement with any third party on an alternate transaction that the Company would consider to be reasonable.

It is important to note that the risks described above as well as in our 2019 Annual Report are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may eventually prove to materially adversely affect our business, results of operations or financial condition.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Recent Sales of Unregistered Securities

There were no unregistered sales of our equity securities during the three-month period ended on March 31, 2020.

Purchases of Equity Securities

During the three months ended March 31, 2020, there were no purchases of our common stock made by, or on behalf of, the Company or any "affiliated purchaser," as defined by Rule 10b-18 of the Exchange Act.

20

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION.

(a) Not applicable.

21

ITEM 6. EXHIBITS. 

2.1	Unit Purchase Agreement dated April 15, 2020, between McorpCX, Inc. and mfifty, LLC (Incorporated by reference to the Company’s Form 8-K filed with the Securities and Exchange Commission on April 16, 2020).
3.1	Articles of Incorporation (Incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).
3.2	Amended Articles of Incorporation (Incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).
3.3	Amended Articles of Incorporation (Incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).
3.4	Amended Articles of Incorporation (Incorporated by reference to the Company’s Form 8-K filed with the Securities and Exchange Commission on July 13, 2015).
3.5	Amended Articles of Incorporation (Incorporated by reference to the Company’s Form 10-Q filed with the Securities and Exchange Commission on November 14, 2016).
3.6	Amended and Restated Bylaws (Incorporated by reference to Exhibit 3. 2.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on November 24, 2015).
31.1	Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).
31.2	Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).
32.1*	Certification of Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
32.2*	Certification of Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension – Schema
101.CAL	XBRL Taxonomy Extension – Calculations
101.DEF	XBRL Taxonomy Extension – Definitions
101.LAB	XBRL Taxonomy Extension – Labels
101.PRE	XBRL Taxonomy Extension – Presentation

*Furnished, not filed

Notes to Exhibits List:

Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting Language): (i) Balance Sheet, (ii) Statements of Operations, (iii) Statements of Cash Flows, and (iv)Notes to the Financial Statements. In accordance with Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101 to this Quarterly Report on Form 10-Q shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be part of any registration statement or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

22

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report has been signed on its behalf by the undersigned, thereunto duly authorized on this 15th day of May 2020.

MCORPCX, INC.
BY:	/s/ Matthew Kruchko
	Matthew Kruchko
	Chief Executive Officer
BY:	/s/ Barry MacNeil
	Barry MacNeil
	Chief Financial Officer

23

EXHIBIT INDEX

2.1	Unit Purchase Agreement dated April 15, 2020, between McorpCX, Inc. and mfifty, LLC (Incorporated by reference to the Company’s Form 8-K filed with the Securities and Exchange Commission on April 16, 2020).
3.1	Articles of Incorporation (Incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).
3.2	Amended Articles of Incorporation (Incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).
3.3	Amended Articles of Incorporation (Incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on April 25, 2012).
3.4	Amended Articles of Incorporation (Incorporated by reference to the Company’s Form 8-K filed with the Securities and Exchange Commission on July 13, 2015).
3.5	Amended Articles of Incorporation (Incorporated by reference to the Company’s Form 10-Q filed with the Securities and Exchange Commission on November 14, 2016).
3.6	Amended and Restated Bylaws (Incorporated by reference to Exhibit 3. 2.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on November 24, 2015).
31.1	Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).
31.2	Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).
32.1*	Certification of Chief Executive Officer and Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350
32.2*	Certification of Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension - Schema
101.CAL	XBRL Taxonomy Extension - Calculations
101.DEF	XBRL Taxonomy Extension - Definitions
101.LAB	XBRL Taxonomy Extension - Labels
101.PRE	XBRL Taxonomy Extension - Presentation

*Furnished, not filed

Notes to Exhibits List:

Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting Language): (i) Balance Sheet, (ii) Statements of Operations, (iii) Statements of Cash Flows, and (iv)Notes to the Financial Statements. In accordance with Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101 to this Quarterly Report on Form 10-Q shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be part of any registration statement or other document filed under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

24

EX-31.1

Exhibit 31.1

SARBANES-OXLEY SECTION 302(a) CERTIFICATION

I, Matthew Kruchko, certify that:

1.	I have reviewed this Form 10-Q for the quarterly period ended March 31, 2020 of McorpCX, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	May 15, 2020	/s/ Matthew Kruchko
		Matthew Kruchko
		Chief Executive Officer

EX-31.2

Exhibit 31.2

SARBANES-OXLEY SECTION 302(a) CERTIFICATION

I, Barry MacNeil, certify that:

1.	I have reviewed this Form 10-Q for the quarterly period ended March 31, 2020 of McorpCX, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	May 15, 2020	/s/ Barry MacNeil
		Barry MacNeil
		Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of McorpCX, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Matthew Kruchko, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated this 15th day of May, 2020.

/s/ Matthew Kruchko

Matthew Kruchko

Chief Executive Officer

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of McorpCX, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Barry MacNeil, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated this 15th day of May, 2020.

/s/ Barry MacNeil

Barry MacNeil

Chief Financial Officer

XML

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue, net
Revenue, net	$ 669,792	$ 1,010,328
Cost of goods sold
Cost of goods sold	259,343	388,400
Gross profit	410,449	621,928
Expenses
Salaries and wages	278,912	293,710
Contract services	3,029	42,180
Other general and administrative	288,783	275,530
Total expenses	570,724	611,420
Net operating (loss) income	(160,275)	10,508
Interest expense		(1,231)
Other expense	(5,576)	(4,500)
Net (loss) income	$ (165,851)	$ 4,777
Net (loss) income per share, basic and diluted (in dollars per share)	$ (0.01)	$ 0
Weighted average common shares outstanding-basic and diluted (in shares)	20,426,158	20,426,158
Service [Member]
Revenue, net
Revenue, net	$ 637,425	$ 965,913
Product and Service, Other [Member]
Revenue, net
Revenue, net	32,367	44,415
Cost of goods sold
Cost of goods sold	43,848	130,248
Product [Member]
Cost of goods sold
Labor	$ 215,495	$ 258,152

XML

Note 2 - Recent Accounting Pronouncements

3 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Accounting Standards Update and Change in Accounting Principle [Text Block]

Note

2

: Recent Accounting Pronouncements

In

March 2020,

the FASB issued ASU

2020

-

04,

Reference Rate Reform (Topic

848

): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU

2020

-

04”

), which contains practical expedients for reference rate reform related activities that impact debt, leases, derivatives and other contracts. The guidance in ASU

2020

-

04

is optional and

may

be elected over time as reference rate reform activities occur. We are currently evaluating the impact of the guidance and our options related to the practical expedients. We don’t expect the adoption of this standard to have a material impact on the consolidated financial statements.

XML

Note 9 - Subsequent Events (Details Textual) - USD ($)	Nov. 01, 2020	Jun. 30, 2020	May 12, 2020	Apr. 30, 2020	Apr. 15, 2020
Forecast [Member]
Paycheck Protection Program, Monthly Loan Payment	$ 6,785
McorpCX [Member] | Forecast [Member]
Initial Cash Payment Received		$ 252,000
Subsequent Event [Member]
Receivable with Imputed Interest, Face Amount					$ 756,000
Interest Receivable					0.99%
Note Receivable, Term (Year)					4 years
Note Receivable, Monthly Principal Payments to be Received					$ 7,292
Proceeds from Paycheck Protection Program Under CARES Act			$ 161,169
Subsequent Event [Member] | McorpCX [Member]
Initial Cash Payment Received		$ 252,000		$ 352,000	$ 100,000

XML

Note 5 - Concentrations (Tables)

3 Months Ended

Mar. 31, 2020

Notes Tables

Schedules of Concentration of Risk, by Risk Factor [Table Text Block]

	2020			2019
Largest client		25	%		35	%
Second largest client		22	%		16	%
Third largest client		20	%		15	%
Next three largest clients		28	%		26	%
All other clients		5	%		8	%
		100	%		100	%

XML

Note 7 - Going Concern

3 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Substantial Doubt about Going Concern [Text Block]

Note

7

: Going Concern

The accompanying consolidated financial statements and notes have been prepared assuming that the Company will continue as a going concern.

We have had material operating losses and have

not

yet created positive cash flows for a full fiscal year. These factors raise substantial doubt as to our ability to continue as a going concern. We continue to focus on our sales pipeline of new business and our cost reduction plans to improve upon our positive working capital of

$626,340

at

March 31, 2020. 

On

April 15, 2020,

McorpCX, Inc., (the "Company") entered into the Purchase Agreement to sell all of the membership interests in McorpCX, LLC, of which the proceeds of

$1,108,000,

consisting of

$352,000

in cash and a

$756,000

promissory note, are expected to be applied to transaction costs as well as investment toward becoming a technology services business. See Note

9

for details. These measures combined with our positive working capital position should enable us to meet our liquidity needs over the next

12

months. Notwithstanding the foregoing, our longer-term ability to continue as a going concern is entirely dependent upon our ability to achieve a level of profitability, and/or to raise additional capital through debt financing and/or through sales of common stock. We cannot provide any assurance that profits from operations, if any, will generate sufficient cash flow to meet our working capital needs and service our existing obligations, nor that sufficient capital can be raised through debt or equity financing. The consolidated financial statements do

not

include adjustments related to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should we be unable to continue as a going concern.

XML

Note 8 - Basic and Diluted Net Income / (Loss) Per Share - Computations for Basic and Diluted Net Income (Loss) Per Share (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net (loss) income	$ (165,851)	$ 4,777
Basic and diluted weighted average common shares outstanding (in shares)	20,426,158	20,426,158
Net (loss) income per share, basic and diluted (in dollars per share)	$ (0.01)	$ 0

XML

Note 5 - Concentrations - Percentage of Sales and the Concentrations (Details) - Customer Concentration Risk [Member] - Revenue Benchmark [Member]	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Concentrations	100.00%	100.00%
Largest Client [Member]
Concentrations	25.00%	35.00%
Second Largest Client [Member]
Concentrations	22.00%	16.00%
Third Largest Client [member]
Concentrations	20.00%	15.00%
Next Three Largest Clients [Member]
Concentrations	28.00%	26.00%
All Other Clients [Member]
Concentrations	5.00%	8.00%

XML

Note 4 - Stock-based Compensation (Details Textual) - USD ($)		3 Months Ended
	Aug. 10, 2016	Mar. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum	10.00%	30.00%
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)		2,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares)		680,000
Share-based Payment Arrangement, Expense		$ 15,730
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount		$ 86,776
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)		0
Share-based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)	10 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)		3 years
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)		1 year 138 days

XML

Note 5 - Concentrations (Details Textual) $ in Thousands	Mar. 31, 2020 USD ($)
Accounts Receivable, Allowance for Credit Loss, Ending Balance	$ 0

XML

Note 3 - Revenues (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue, Remaining Performance Obligation, Amount	$ 530
Contract with Customer, Liability, Revenue Recognized	$ 31,828	$ 75,105

XML

Note 8 - Basic and Diluted Net Income / (Loss) Per Share (Details Textual) - shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	680,000	1,350,000

XML

Note 3 - Revenues

3 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Revenue from Contract with Customer [Text Block]

Note

3

. Revenues

Consulting Service Revenues

The Company’s consulting services are project based and include the articulation of customer-centric strategies and implementation roadmaps in support of these strategies. The performance obligation in these projects is the delivery of specific findings reports as it pertains to the analysis of a client customer’s experience. These projects include milestone payments for completion of different phases of the project and are included in the transaction price. These milestone payments are deemed to be fixed because the milestones are within the control of the Company. The projects also include reimbursable expenses, which are part of the transaction price and deemed variable consideration. These reimbursable expenses are estimated at contract inception. Given the confidentiality provisions in the agreement and the nature of the services being performed, the Company has

no

alternative use for the specific findings report. Therefore, the Company recognizes the transaction price over time, based on percentage of completion of the milestones in the contract.

Product and other revenue

Product and other revenue during

2020

and

2019

has primarily been derived from reimbursable expenses charged to clients. The product related portion of this revenue originates from the utilization of the Company’s web-hosted Touchpoint Mapping On-Demand application (“Touchpoint Mapping”), which is designed to gather customer satisfaction data, track brand perceptions, and analyze results. Touchpoint Mapping is a SaaS (Software as a Service) subscription-based technology application, which derives revenue from the following sources: nonrefundable setup fees, subscription fees, professional service fees, and consulting fees related to implementation, customization, configuration, training, and other value-added services. Customer licenses for Touchpoint Mapping are

not

subject to the licensing guidance in Topic

606

because the customer can’t take possession of the software at any time and the customer would

not

be able to operate the software on its own or with another

third

party. Fees charged to customers of Touchpoint Mapping

may

include implementation, setup, training and license fees for the application. Revenue generated from Touchpoint Mapping (either directly through licensing fees or fees received through support functions) is recognized on a straight-line basis because the Company’s obligations under its contracts concerning Touchpoint Mapping are deemed to be stand-ready obligations due to the fact that the Company is contractually required to provide access to Touchpoint Mapping and customer support on a daily basis. Consequently, usage of Touchpoint Mapping by customers does

not

affect the ability of customers to access the application or our customer support functions. For these reasons, revenue is recognized on a straight-line basis over the contract period. If billings are front loaded, this will result in a deferral of revenue during the contract period. For recognition purposes, we do

not

unbundle such services into separate performance obligations as their pattern of transfer does

not

differ.

Deferred Revenues (Contract Liabilities)

The Company records deferred revenues when cash payments are received, including amounts which are refundable.

Payment terms vary by customer and the products or services offered. The term between invoicing and when payment is due is

not

significant. For certain products or services and customer types, full or a partial payment of the entire contract is required before the products or services are delivered to the customer.

The aggregate amount of the fees received from customers that are allocated to each customer’s respective performance obligation that is unsatisfied (or partially unsatisfied) is

$530

as of

March 31, 2020

and included in deferred revenue on the accompanying consolidated balance sheets. The Company expects to recognize revenue of

$530

in

2020

related to these unsatisfied (or partially unsatisfied) performance obligations. Deferred revenue is

not

expected to be recognized beyond fiscal year

2021.

During the

three

months ended

March 31, 2020

and

2019,

we recognized revenue of

$31,828

and

$75,105,

related to our contract liabilities included in deferred revenue at

December 31, 2019

and

2018,

respectively.

Practical Expedients and Exemptions

Contract costs consist primarily of sales commissions. The Company generally expenses sales commissions when incurred because the amortization period would have been

one

year or less and the commissions are only due and payable upon receipt of payment from the client. These costs are recorded within sales and marketing expenses.

The Company does

not

disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of

one

year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.

XML

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2020	May 13, 2020
Document Information [Line Items]
Entity Registrant Name	McorpCX, Inc.
Entity Central Index Key	0001535079
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding (in shares)		20,426,158
Entity Shell Company	false
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML

Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2018	20,426,158
Balance at Dec. 31, 2018		$ 6,454,791	$ (4,834,173)	$ 1,620,618
Stock based compensation - stock options		15,558		15,558
Net (loss) income			4,777	4,777
Balance (in shares) at Mar. 31, 2019	20,426,158
Balance at Mar. 31, 2019		6,470,349	(4,829,396)	$ 1,640,953
Balance (in shares) at Dec. 31, 2019	20,426,158			20,426,158
Balance at Dec. 31, 2019		6,517,885	(5,595,128)	$ 922,757
Stock based compensation - stock options		15,730		15,730
Net (loss) income			(165,851)	$ (165,851)
Balance (in shares) at Mar. 31, 2020	20,426,158			20,426,158
Balance at Mar. 31, 2020		$ 6,533,615	$ (5,760,979)	$ 772,636

XML

Note 4 - Stock-based Compensation (Tables)

3 Months Ended

Mar. 31, 2020

Notes Tables

Share-based Payment Arrangement, Activity [Table Text Block]

					Weighted
			Weighted		Average
			Average		Remaining		Aggregate
	Number of		Exercise		Contractual		Intrinsic
	Shares		Price		Term (in years)		Value
Outstanding at December 31, 2019		1,140,000	$	0.35		6.25		-
Granted		-		-		-		-
Exercised		-		-		-		-
Cancelled		-		-		-		-
Forfeited or expired		-		-		-		-
Outstanding at March 31, 2020		1,140,000	$	0.35		6.00		-
Exercisable at March 31, 2020		680,000	$	0.43		4.39	$	-

Schedule of Nonvested Share Activity [Table Text Block]

Nonvested options
	Number of
	Shares
Nonvested options at December 31, 2019		460,000
Granted		-
Exercised		-
Cancelled		-
Forfeited or expired		-
Vested		-
Nonvested options at March 31, 2020		460,000

XML

Note 6 - Leases

3 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Lessee, Operating Leases [Text Block]

Note

6:

Leases

In

2019,

the Company adopted the provisions of Accounting Standards Update

2016

-

02,

Leases, effective

January 1, 2019.

We determined if an arrangement is a lease at inception. Operating lease right-of-use (“ROU”) assets are recorded in other assets and operating lease liabilities are recorded in current liabilities in the accompanying consolidated balance sheets. Finance leases,

none

of which existed as of the adoption of Accounting Standards Codification (“ASC”)

842

or as of

December 31, 2019,

would be reflected in property and equipment and other liabilities in our consolidated balance sheets.

ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do

not

provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms

may

include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

Under the available practical expedient, we account for the lease and non-lease components as a single lease component for all classes of underlying assets. Further, we elected a short-term lease exception policy on all classes of underlying assets, permitting us to

not

apply the recognition requirements of this standard to short-term leases (i.e. leases with terms of

12

months or less). 

Effective

January 1, 2020,

the Company’s leased office space in San Anselmo, California which was originally scheduled to expire on

March 31, 2020

was renegotiated and treated as a modified lease for a

6

-month term and monthly rent of

$2,539

and will expire

September 30, 2020.

As of

January 1, 2020,

the impact of the modified lease with a discount rate of

6%

resulted in the recognition of a right of use asset of

$21,700,

included in other assets, and lease payable obligation on the Company’s consolidated balance sheets of

$22,405.

Lease expense was

$13,955

and

$6,833

for the

three

months ended

March 31, 2020

and

2019,

respectively, which is included in the general and administrative expense in the accompanying consolidated statements of operations.

XML

Note 6 - Leases (Details Textual) - USD ($)		3 Months Ended
	Jan. 01, 2020	Mar. 31, 2020	Mar. 31, 2019
Lessee, Operating Lease, Discount Rate	6.00%
Operating Lease, Right-of-Use Asset	$ 21,700
Operating Lease, Liability, Current		$ 22,405
Operating Lease, Expense		$ 13,955	$ 6,833
Northern California Facility [Member]
Lessee, Operating Lease, Term of Contract (Month)	180 days
Lease and Rental Expense, Per Month	$ 2,539

XML

Note 4 - Stock-based Compensation - Stock Option Activity (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Options outstanding, balance (in shares)	1,140,000
Weighted average exercise price, outstanding balance (in dollars per share)	$ 0.35
Weighted average remaining contractual term, outstanding balance (Year)	6 years	6 years 91 days
Aggregate intrinsic value, outstanding balance
Options granted (in shares)	0
Weighted average exercise price, options granted (in dollars per share)
Weighted average remaining contractual term, Granted (Year)
Options exercised (in shares)
Weighted average exercise price, options exercised (in dollars per share)
Options cancelled (in shares)
Weighted average exercise price, options cancelled (in dollars per share)
Options outstanding, balance (in shares)	1,140,000	1,140,000
Weighted average exercise price, outstanding balance (in dollars per share)	$ 0.35	$ 0.35
Options exercisable (in shares)	680,000
Weighted average exercise price, options exercisable (in dollars per share)	$ 0.43
Weighted average remaining contractual term, options exercisable (Year)	4 years 142 days
Aggregate intrinsic value, options exercisable

XML

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares $ / shares in Thousands	Mar. 31, 2020	Dec. 31, 2019
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	20,426,158	20,426,158
Common stock, shares outstanding (in shares)	20,426,158	20,426,158

XML

Note 1 - Organization and Basis of Presentation

3 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

Note

1:

Organization and Basis of Presentation

McorpCX, Inc. (“we,” “us,” “our,” or the “Company””) was incorporated in the State of California on

December 14, 2001.

We are a customer experience (CX) management solutions company dedicated to helping organizations improve customer experiences, increase customer loyalty, reduce costs and increase revenue. The Company operated as The Innes Group, Inc., d/b/a MCorp Consulting until filing a Certificate of Amendment to the Articles of Incorporation renaming the Company Touchpoint Metrics, Inc., effective

October 18, 2011.

During

Q1

2015,

the Company filed a d/b/a (doing business as) with the State of California Secretary of State to begin doing business as McorpCX. On

June 11, 2015,

at our Annual General Meeting, shareholders passed a resolution to change the name of the Company to McorpCX, Inc.

The Company formed a wholly owned subsidiary, McorpCX, LLC (“McorpCX LLC”) as a limited liability company in the state of Delaware on

December 14, 2017.

On

August 16, 2018,

the Company entered into a contribution agreement with its wholly owned subsidiary McorpCX LLC, pursuant to which the Company transferred to McorpCX LLC all of the Company’s assets and liabilities related to the Company’s customer experience consulting business, excluding the underlying technology and databases related thereto which remained with the Company.

We are a customer experience services company, currently focused on delivering consulting and technology solutions to customer-centric organizations. We are engaged in the business of delivering consulting and professional services that are designed to help corporations improve their customer listening and customer experience management capabilities. To augment our consultative solutions, we have developed technology products that include on-demand “cloud based” customer experience management software. Our professional and related services include a range of customer experience management services such as research, training, strategy consulting and process optimization. 

On

April 15, 2020,

the Company entered into a definitive purchase agreement (the “Purchase Agreement”) to sell all of the membership interests in McorpCX, LLC to mfifty, LLC, a California limited liability company controlled by Michael Hinshaw, the current President of McorpCX, LLC (the “

Purchaser

”). The Purchase Agreement provides that as consideration for the sale of McorpCX, LLC, the Company will receive a total consideration of

$1,108,000

consisting of

$100,000

in cash received upon the signing of the Purchase Agreement and

$252,000

in cash to be received at the closing of the transaction along with a

$756,000

promissory note.

The transaction is expected to close in

June 2020,

subject to the approval of the majority of the outstanding shares of the Company held by disinterested shareholders. Upon completion of the sale of McorpCX, LLC, the Company intends on focus on growing the Company’s software development and technology services business.

The consolidated financial statements and related disclosures as of and for the

three

months ended

March 31, 2020

and

2019,

are unaudited, pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC"). The consolidated balance sheet as of

December 31, 2019

was derived from the audited consolidated financial statements included in our Annual Report on Form

10

-K for the year ended

December 31, 2019.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. In our opinion, these consolidated financial statements include all adjustments (consisting only of normal recurring adjustments) necessary for the fair statement of the results for the interim periods. These consolidated financial statements should be read in conjunction with the consolidated financial statements included in our Annual Report for the year ended

December 31, 2019,

filed on Form

10

-K with the SEC on

March 27, 2020. 

The results of operations for the

three

months ended

March 31, 2020,

are

not

necessarily indicative of the results to be expected for the full year.

XML

Note 8 - Basic and Diluted Net Income / (Loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2020

Notes Tables

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	Three Months Ended
	March 31,
	2020			2019
Net (loss) income	$	(165,851	)	$	4,777
Basic and diluted weighted average common shares outstanding		20,426,158			20,426,158
Net (loss) income per share, basic and diluted	$	(0.01	)	$	0.00

XML

Note 8 - Basic and Diluted Net Income / (Loss) Per Share

3 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Earnings Per Share [Text Block]

Note

8

:

Basic and Diluted Net Income / (Loss) per Share

Net income (loss) per share was computed by dividing the net income (loss) by the weighted average number of common shares outstanding during the period. The weighted average number of shares was calculated by taking the number of shares outstanding and weighting them by the amount of time that they were outstanding. For the

three

months ended

March 31, 2020

and

2019,

the assumed exercise of share options is anti-dilutive and are excluded from the determination of net income (loss) per share – basic and diluted. The share options were anti-dilutive due to the Company’s net loss or the Company’s common stock average market price was less than the share options exercise price. Accordingly, net (loss) / income per share basic and diluted are equal in all periods presented. Securities that were

not

included in the diluted per share calculations because they would be anti-dilutive were options to purchase common stock of

680,000

and

1,350,000

for the

three

months ended

March 31, 2020

and

2019,

respectively.

	Three Months Ended
	March 31,
	2020			2019
Net (loss) income	$	(165,851	)	$	4,777
Basic and diluted weighted average common shares outstanding		20,426,158			20,426,158
Net (loss) income per share, basic and diluted	$	(0.01	)	$	0.00

XML

Note 4 - Stock-based Compensation

3 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Share-based Payment Arrangement [Text Block]

Note

4

: Stock-Based Compensation

Our stock-based compensation plan was originally established in

2008.

The shares of our common stock issuable pursuant to the terms of such plan (the “Plan Shares”) could

not

exceed

30%

of any outstanding issue or

2,500,000

shares, whichever was the lower amount.

In

December 2015,

we adopted a revised share option plan in which Plan Shares cannot exceed

10%

of the total issued and outstanding shares at any given time. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of the grant and all option grants have a

10

-year term. This share option plan was initially approved by the Company’s shareholders at the annual meeting of shareholders on

August 10, 2016

and has subsequently been re-approved at each subsequent annual meeting of the Company’s stock holders since that date, as required under applicable TSX-V rules.

To calculate the fair value of stock options at the date of grant, we use the Black-Scholes option pricing model. The volatility used is based on a blended historical volatility of our own stock and similar sized companies due to the limited historical data available for our own stock price. The expected term was determined based on the simplified method outlined in Staff Accounting Bulletin

No.

110.

The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

The following table summarizes our stock option activity for the

three

months ended

March 31, 2020:

					Weighted
			Weighted		Average
			Average		Remaining		Aggregate
	Number of		Exercise		Contractual		Intrinsic
	Shares		Price		Term (in years)		Value
Outstanding at December 31, 2019		1,140,000	$	0.35		6.25		-
Granted		-		-		-		-
Exercised		-		-		-		-
Cancelled		-		-		-		-
Forfeited or expired		-		-		-		-
Outstanding at March 31, 2020		1,140,000	$	0.35		6.00		-
Exercisable at March 31, 2020		680,000	$	0.43		4.39	$	-

At

March 31, 2020,

680,000

stock options were exercisable and

$15,730

of total compensation cost related to share-based compensation grants had been recognized for the

three

months ended

March 31, 2020.

Unrecognized compensation expense from stock options was

$86,776

at

March 31, 2020,

which is expected to be recognized over a weighted-average vesting period of

1.38

years beginning

April 1, 2020.

There were

no

options granted during the

three

months ended

March 31, 2020.

A summary of the status of the Company’s nonvested options as of

March 31, 2020,

is presented below:

Nonvested options
	Number of
	Shares
Nonvested options at December 31, 2019		460,000
Granted		-
Exercised		-
Cancelled		-
Forfeited or expired		-
Vested		-
Nonvested options at March 31, 2020		460,000

XML

Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 438,461	$ 588,848
Accounts receivable	399,338	486,317
Total current assets	837,799	1,075,165
Long term assets:
Property and equipment, net	86,920	87,551
Other assets	59,376	55,444
Total assets	984,095	1,218,160
Liabilities:
Accounts payable and accrued liabilities	194,199	253,824
Deferred revenue	530	32,358
Lease payable	15,048	7,539
Other current liabilities	1,682	1,682
Total current liabilities	211,459	295,403
Total liabilities	211,459	295,403
Shareholders' equity:
Common stock, no par value, 500,000,000 shares authorized, 20,426,158 shares issued and outstanding at March 31, 2020 and December 31, 2019
Additional paid-in capital	6,533,615	6,517,885
Accumulated deficit	(5,760,979)	(5,595,128)
Total shareholders' equity	772,636	922,757
Total liabilities and shareholders' equity	$ 984,095	$ 1,218,160

XML

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) income	$ (165,851)	$ 4,777
Adjustments to reconcile net (loss) income to net cash (used in) provided by operations:
Depreciation and amortization	631	50,148
Operating lease ROU asset amortization	13,955
Stock compensation expense	15,730	15,558
Changes in operating assets and liabilities:
Accounts receivable	86,979	(39,336)
Other assets	3,813	9,273
Accounts payable and accrued liabilities	(59,625)	101,004
Lease liability	(14,191)	(5,225)
Other current liabilities		146
Deferred revenue	(31,828)	96,576
Net cash (used in) provided by operating activities	(150,387)	232,921
Net cash used in investing activities
Net cash used in financing activities
(Decrease) increase in cash and cash equivalents	(150,387)	232,921
Cash and cash equivalents, beginning of period	588,848	1,350,014
Cash and cash equivalents, end of period	438,461	1,582,935
Supplemental disclosure of cash flow information:
Interest paid		1,231
Initial recognition of ROU asset and lease liability	21,700
Accounting Standards Update 2016-02 [Member]
Supplemental disclosure of cash flow information:
Initial recognition of ROU asset and lease liability		$ 34,164

XML

Note 9 - Subsequent Events

3 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Subsequent Events [Text Block]

Note

9

:

Subsequent Events

On

April 15, 2020,

the Company entered into the Purchase Agreement to sell all of the membership interests in McorpCX, LLC, to the Purchaser. Since the Company’s professional and related consulting services business, which currently constitutes substantially all of the Company’s operations, is conducted through McorpCX, LLC, the sale of McorpCX, LLC constitutes the sale of substantially all of the Company’s assets under the California Corporations Code, and as such, the Company will be seeking stockholder approval of the Purchase Agreement.

The Purchase Agreement provides that as consideration for the sale of McorpCX, LLC, the Company will receive a total of

$352,000

in cash consisting of

$100,000

received upon the signing of the Purchase Agreement and

$252,000

to be received at the closing of the transaction along with a

$756,000

promissory note. The promissory note has an initial annual interest rate of

0.99%

(to be recalculated at the end of each

twelve

month period subsequent to the date of the note based on the annual Applicable Federal Rate for mid-term loans on the

first

business day following each such

twelve

month period) accruing daily on the outstanding balance of the note, and monthly principal payments are to be payable to the Company over a term of

four

or more years. Monthly principal payments to the Company are initially

$7,292

per month for the

first

twelve

months following the date of the note, and then during each subsequent

twelve

month period are to be based on the annual revenues of McorpCX, LLC.

The sale of McorpCX, LLC is subject to the approval of the Purchase Agreement by the majority of the outstanding shares of the Company held by disinterested shareholders, the approval of the TSX Venture Exchange, the sale of all of the Company’s shares of common stock currently owed by Mr. Hinshaw to

third

parties on terms reasonably satisfactory to the Company, and the satisfaction of customary closing conditions.

The transaction is expected to close in

June 2020,

subject to the approval of the majority of the outstanding shares of the Company held by disinterested shareholders.

On

May 12, 2020,

the Company received an unsecured non-recourse promissory note in the amount of

$161,169

under the Paycheck Protection Program. In

March 2020,

the Coronavirus Aid, Relief, and Economic Security Act was passed in the United States, which included amongst other programs, loans to businesses under a Paycheck Protection Program. The Paycheck Protection Program Note incurs interest at a fixed rate of

1.00%

and is schedule to mature on

May 3, 2022.

The Company is required to make monthly payments on the note of

$6,785

commencing on

November 1, 2020.

XML

Note 5 - Concentrations

3 Months Ended

Mar. 31, 2020

Notes to Financial Statements

Concentration Risk Disclosure [Text Block]

Note

5

: Concentrations 

We sell products and services under various terms to a broad range of companies across multiple industries ranging from start-ups to Fortune

500

companies, with sales historically concentrated among a few large clients. We continue to make efforts to mitigate risk from loss of a single client and shift sales concentration to a more even distribution among our clients. For the

three

months ended

March 31, 2020

and

2019,

the percentage of sales and the concentrations are:

	2020			2019
Largest client		25	%		35	%
Second largest client		22	%		16	%
Third largest client		20	%		15	%
Next three largest clients		28	%		26	%
All other clients		5	%		8	%
		100	%		100	%

Sales are made without collateral and the credit-related losses have been insignificant or non-existent. Accordingly, there is

no

provision made to include an allowance for doubtful accounts.

XML

Note 1 - Organization and Basis of Presentation (Details Textual) - USD ($)	Jun. 30, 2020	Apr. 30, 2020	Apr. 15, 2020
McorpCX [Member] | Forecast [Member]
Initial Cash Payment Received	$ 252,000
Subsequent Event [Member]
Receivable with Imputed Interest, Face Amount			$ 756,000
Subsequent Event [Member] | McorpCX [Member]
Proceeds from Sale of Intangible Assets			1,108,000
Initial Cash Payment Received	$ 252,000	$ 352,000	$ 100,000

XML

Note 7 - Going Concern (Details Textual) - USD ($)	Jun. 30, 2020	Apr. 30, 2020	Apr. 15, 2020	Mar. 31, 2020
Working Capital				$ 626,340
Subsequent Event [Member]
Receivable with Imputed Interest, Face Amount			$ 756,000
Subsequent Event [Member] | McorpCX [Member]
Proceeds from Sale of Intangible Assets			1,108,000
Initial Cash Payment Received	$ 252,000	$ 352,000	$ 100,000

XML

Note 4 - Stock-based Compensation - Nonvested Options (Details)	3 Months Ended
	Mar. 31, 2020 shares
Nonvested options (in shares)	460,000
Granted (in shares)	0
Vested (in shares)
Nonvested options (in shares)	460,000